Beyond BMI: Why Body Composition Matters for Healthy Aging

For clinicians working in longevity, preventive health, hormone health and healthy aging, maintaining a healthy body weight is only one part of the picture. As patients age, meaningful changes can occur in visceral adiposity, skeletal muscle and overall body composition without producing an equally meaningful change on the scale.

This creates an important limitation when weight or BMI is used as the primary measure of health or progress. Neither can show what that weight is made up of, where adipose tissue is distributed or whether the balance between fat and muscle is changing over time.

This distinction is increasingly reflected in clinical thinking. In 2025, The Lancet Diabetes & Endocrinology Commission on clinical obesity concluded that BMI can both underestimate and overestimate adiposity at an individual level and does not provide sufficient information about body-fat distribution or individual health when considered alone.[1] For clinicians whose focus extends beyond disease management toward preserving metabolic health, physical function and independence, this is particularly relevant.

Aging can change body composition without changing body weight

Aging is associated with changes in both the amount and distribution of adipose tissue alongside progressive changes in skeletal muscle. These processes are not necessarily accompanied by substantial changes in overall body weight.

Research into adipose tissue aging shows a shift toward greater accumulation of intra-abdominal visceral and ectopic fat, alongside cellular and metabolic changes associated with inflammation, insulin resistance and cardiovascular dysfunction.[2] At the same time, age-related changes in muscle quantity, quality and strength become increasingly relevant to physical function and independence.[3]

The result is that a patient's weight or BMI may remain relatively stable while their underlying body composition changes considerably.

Long term data illustrate why this matters. In the Health, Aging and Body Composition Study, older adults experienced changes across multiple tissue compartments, including lean mass, fat mass and muscle area. Importantly, greater loss of thigh muscle than would be expected from overall weight change was associated with a higher risk of mortality.[4]

From a healthy-aging perspective, the implication is important: weight stability is not necessarily body-composition stability.

The issue is not simply how much weight a patient carries, but what that weight represents

BMI remains a practical and widely used screening measure. Its limitation is not that it has no clinical value, but that it cannot distinguish fat mass from muscle or characterize adipose tissue distribution.

Two patients with the same BMI may therefore have very different body-composition profiles. One may have relatively greater skeletal muscle and lower visceral adiposity, while another may have lower muscle mass combined with greater central adiposity. Their BMI classification may look similar, but their metabolic and functional profiles may not be.

This becomes particularly relevant when excess adiposity and declining muscle occur together.

Sarcopenic obesity — broadly characterized by the coexistence of obesity and impaired muscle health — demonstrates why considering both compartments matters. A recent systematic review and meta-analysis of 16 studies involving 578,408 participants found that sarcopenic obesity was associated with a 95% higher risk of cardiovascular disease and a 64% higher risk of cardiovascular mortality compared with those without the phenotype.[5]

These figures should not be interpreted to mean that a body-composition scan diagnoses cardiovascular risk or sarcopenic obesity. They do, however, illustrate why looking at adiposity or body weight without also considering muscle can obscure clinically relevant information.

For clinicians focused on healthspan, the question becomes less about what a patient weighs in isolation and more about what is changing within that weight over time.

Healthy aging requires monitoring both sides of the equation

Traditional weight-management conversations have understandably focused on reducing excess body weight. In longevity and preventive health, however, the composition of that change is also important.

Reducing excessive adiposity may support improvements in metabolic health, while preserving muscle is important for maintaining strength and physical function with age. International consensus on sarcopenia now places particular emphasis on muscle strength, with muscle quantity and quality used to support diagnosis and physical performance helping establish severity.[6]

This means an apparently successful reduction in body weight can represent very different physiological outcomes.

A patient losing fat while maintaining muscle is following a different trajectory from a patient losing substantial amounts of both. Equally, a patient whose body weight has changed very little may still be experiencing a favorable shift in body composition.

Weight alone cannot distinguish between these scenarios.

This is why body-composition assessment can provide useful additional context within longevity, hormone-health, medical weight-management and preventive-health programs.

Long term data is where body composition becomes particularly valuable

The clinical value of body-composition assessment is not simply in generating more measurements. Its value lies in understanding direction of change.

A baseline body-composition assessment establishes a starting point. Subsequent measurements can then provide additional information about how fat and muscle are changing during an intervention.

This can alter the interpretation of conventional weight data.

A patient whose weight has plateaued may still be reducing fat mass while preserving or increasing skeletal muscle. From a scale-only perspective, progress appears to have stopped. From a body-composition perspective, meaningful change may still be taking place.

The reverse is equally important. Significant weight loss may initially appear favorable but warrant closer consideration if accompanied by disproportionate loss of muscle.

A 2025 review specifically addressing body composition across the lifespan concluded that measures including skeletal muscle, fat mass and visceral adipose tissue provide health information beyond BMI and can be particularly valuable for long term assessment.[3]

For longevity practices, that long term perspective matters. Healthy aging is not defined by a single measurement at a single point in time; it is about the trajectory of metabolic and functional health over years.

Making healthspan more measurable

Healthspan is inherently broader than body composition. Blood pressure, glucose regulation, lipids, cardiovascular fitness, strength, mobility, sleep and other clinical and functional markers can all contribute to understanding how well a person is aging.

Body composition provides another important layer to that picture.

Monitoring measures such as visceral fat, total fat mass and skeletal muscle allows practitioners to see changes that cannot be identified through weight and BMI alone. When interpreted alongside clinical biomarkers, functional assessments and the wider patient picture, these measures can help clinicians understand whether an intervention is moving body composition in the intended direction.

No single body-composition metric should be interpreted as a diagnosis, and practical assessment methods should not be positioned as equivalent to reference imaging techniques such as CT or MRI.

Bioelectrical impedance analysis, or BIA, provides one practical option for repeat body-composition assessment. A 2024 systematic review identified more than 100 published predictive equations used in BIA and emphasized that interpretation depends on factors including the device and equation used, age, sex, health status, activity level and population characteristics.[7]

Used consistently and within its intended scope, BIA can therefore provide clinicians with a practical way to monitor changes in body composition alongside other measures of health.

Beyond BMI means understanding the direction of change

For longevity and preventive-health clinicians, the argument for body composition is ultimately straightforward.

A scale can show whether weight has changed. BMI can relate that weight to height.

Neither can show whether an aging patient is accumulating visceral fat, losing muscle, improving one while preserving the other, or undergoing meaningful compositional change despite apparently stable weight.

Those distinctions matter because healthy aging is not simply about maintaining or reducing kilograms. It is about supporting the metabolic and physical characteristics that contribute to health, function and independence for as long as possible.

Body-composition assessment gives clinicians another way to observe that trajectory and evaluate whether interventions are changing the body in the direction intended.

Tracking body composition with Evolt 360

Evolt 360 uses bioelectrical impedance analysis to provide body-composition estimates including skeletal muscle mass, fat mass and visceral fat rating, alongside additional metrics that can be monitored over time.

For longevity, preventive-health, hormone-health and weight-management practices, incorporating repeat body-composition assessment alongside existing clinical and functional measures can provide greater visibility into changes that body weight and BMI alone cannot show.

Discover how Evolt 360 can support long term body-composition monitoring within your healthy-aging practice.

References

1. Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221–262. doi:10.1016/S2213-8587(24)00316-4.

2. Ahmed B, Farb MG, Gokce N. Cardiometabolic implications of adipose tissue aging. Obes Rev. 2024;25(11):e13806. doi:10.1111/obr.13806.

3. Bennett JP, Lim S. The critical role of body composition assessment in advancing research and clinical health risk assessment across the lifespan. J Obes Metab Syndr. 2025;34(2):120–137. doi:10.7570/jomes25010.

4. Santanasto AJ, Goodpaster BH, Kritchevsky SB, et al. Body composition remodeling and mortality: The Health, Aging and Body Composition Study. J Gerontol A Biol Sci Med Sci. 2017;72(4):513–519. doi:10.1093/gerona/glw163.

5. Zhang Z, Zeng X. Sarcopenic obesity and cardiovascular disease risk and mortality: A systematic review and meta-analysis. Anatol J Cardiol. 2026;30(2):73–82. doi:10.14744/AnatolJCardiol.2025.5635.

6. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169.

7. Campa F, Coratella G, Cerullo G, et al. High-standard predictive equations for estimating body composition using bioelectrical impedance analysis: a systematic review. J Transl Med. 2024;22:515. doi:10.1186/s12967-024-05272-x.

‍